Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong
· Delayed Price · Currency is HKD 74.90
-4.10 (-5.19%)
At close: Apr 29, 2026
HKG:2659 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 1,242 | 524.16 | 321.67 |
| Short-Term Investments | 1.33 | 1.18 | 2.46 |
| Cash & Short-Term Investments | 1,243 | 525.33 | 324.13 |
| Cash Growth | 136.60% | 62.08% | - |
| Accounts Receivable | 0.1 | 0.14 | 2 |
| Other Receivables | - | - | 0.04 |
| Receivables | 0.1 | 0.14 | 2.04 |
| Inventory | 6.25 | 4.72 | 8.07 |
| Prepaid Expenses | 0.84 | 0.83 | 1.05 |
| Other Current Assets | 113.03 | 134.56 | 30.85 |
| Total Current Assets | 1,363 | 665.58 | 366.15 |
| Property, Plant & Equipment | 734.26 | 677.13 | 585.42 |
| Long-Term Investments | 10.81 | 7.83 | 8.44 |
| Other Intangible Assets | 11.69 | 12.32 | 12.57 |
| Other Long-Term Assets | 97.06 | 0.41 | 1.31 |
| Total Assets | 2,217 | 1,363 | 973.88 |
| Accounts Payable | 0.01 | 0.34 | - |
| Accrued Expenses | 18.33 | 20.44 | 12.14 |
| Short-Term Debt | - | 29.83 | 20.02 |
| Current Portion of Long-Term Debt | 113.96 | 39.74 | 45.09 |
| Current Portion of Leases | 1.61 | 1.56 | 0.92 |
| Current Income Taxes Payable | 3.47 | 1.16 | 0.98 |
| Current Unearned Revenue | 6.41 | 58.37 | 18.36 |
| Other Current Liabilities | 186.87 | 44.79 | 49.31 |
| Total Current Liabilities | 330.65 | 196.23 | 146.82 |
| Long-Term Debt | 198.45 | 132.29 | 44.98 |
| Long-Term Leases | 0.98 | 1.84 | 0.1 |
| Long-Term Unearned Revenue | 94.92 | 37.03 | 32.83 |
| Long-Term Deferred Tax Liabilities | - | - | 0.02 |
| Total Liabilities | 625.01 | 367.39 | 224.75 |
| Common Stock | 65.2 | 57.26 | 52.05 |
| Additional Paid-In Capital | - | 1,453 | 1,000 |
| Retained Earnings | - | -667.66 | -303.23 |
| Comprehensive Income & Other | 1,527 | 153.15 | - |
| Shareholders' Equity | 1,592 | 995.88 | 749.13 |
| Total Liabilities & Equity | 2,217 | 1,363 | 973.88 |
| Total Debt | 315 | 205.26 | 111.12 |
| Net Cash (Debt) | 927.95 | 320.08 | 213.01 |
| Net Cash Growth | 189.91% | 50.26% | - |
| Net Cash Per Share | 3.20 | 1.20 | 0.84 |
| Filing Date Shares Outstanding | 292.43 | 286.3 | 252.96 |
| Total Common Shares Outstanding | 292.43 | 286.3 | 252.96 |
| Working Capital | 1,033 | 469.35 | 219.32 |
| Book Value Per Share | 5.44 | 3.48 | 2.96 |
| Tangible Book Value | 1,580 | 983.56 | 736.56 |
| Tangible Book Value Per Share | 5.40 | 3.44 | 2.91 |
| Buildings | - | 199.13 | 199.13 |
| Machinery | - | 176.61 | 164.47 |
| Construction In Progress | - | 302.12 | 199.59 |
Source: S&P Capital IQ. Standard template. Financial Sources.